(Press-News.org) Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.
A new Phase 2 clinical trial at UC Davis Comprehensive Cancer Center unveiled clues as to why these patients are doing poorly and may offer hope in the form of targeted therapy.
The findings will be presented at the annual American Society of Clinical Oncology (ASCO) conference on June 3 in Chicago. .
Pilot trial sheds new clues
UC Davis Comprehensive Cancer Center is testing a drug called niraparib (ZEJULA), given before prostate cancer surgery. Researchers think it could enable more personalized treatments— especially for men with prostate cancer that has specific DNA repair gene mutations.
The pilot trial (NCT04030559) looked at whether giving the PARP inhibitor niraparib before surgery could help prevent cancer from returning in men with aggressive prostate cancer.
A total of 11 men with high-risk prostate cancer and certain biomarkers, specifically gene mutations, took part in the study. Each patient received 200 mg of niraparib daily for 90 days before undergoing surgery.
The study group had a median age of 68 years and a median prostate-specific antigen (PSA) at diagnosis of 10.7 ng/mL. Genetic alterations included germline mutations in BRCA2, MSH6, and CHEK2, and somatic mutations in ATM, SPOP, KMT2C, KMT2D, among others. Germline mutations in DNA are inherited while somatic mutations happen after conception.
Outcome shows the complexity of prostate cancer
While the drug didn’t dramatically shrink tumors before surgery, the study showed the potential of using genetic testing and blood-based monitoring to better understand and track prostate cancer. Notably, circulating tumor DNA (ctDNA) biomarker analysis proved useful in tracking tumor evolution and resistance mechanisms in real time. ctDNA is small fragments of DNA that cancer cells release into the bloodstream.
“This study shows how complex prostate cancer can be, especially in men with certain gene mutations,” said Marc Dall’Era, chief of UC Davis Health’s Department of Urologic Surgery and lead researcher. “Although responses were variable, especially in patients with BRCA2 mutations, this study points to ctDNA as a promising tool to identify who might benefit from targeted neoadjuvant therapies.”
The research team is now continuing to analyze the data to better understand why some cancers resist treatment and how to design future therapies that are more tailored to each individual.
Other researchers included Primo Lara Jr., Nicholas Mitsiades, Mamta Parikh, John McPherson and Kenneth Iczkowski, Irene Mitsiades and Aedric Lim.
Jannsen Pharmaceuticals funded the clinical trial.
END
UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
Clinical trial tests new treatment approach, offers hope for personalized therapies
2025-05-30
ELSE PRESS RELEASES FROM THIS DATE:
UT Health San Antonio researchers discover new links between heart disease and dementia
2025-05-30
SAN ANTONIO, May 30, 2025 – People who are at higher risk for heart disease also seem more likely to develop dementia.
And research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered new associations between various lipid, or fat, levels in the blood and the risk of developing Alzheimer’s disease, the most common cause of dementia worldwide.
The findings mean that using blood lipid profiles could help better understand, predict and possibly even prevent the disease in the future.
In more than 800 older adults who were part of the long-running Framingham Heart Study, the researchers ...
AADOCR announces new SCADA/Dentsply Sirona Research Award
2025-05-30
Alexandria, VA – AADOCR and the Student Competition for Advancing Dental Research and its Application (SCADA) Alumni Association are pleased to announce the AADOCR SCADA/Dentsply Sirona Research Award.
The new award was created to support dentist-scientists, including SCADA program alumni, in their research careers. The award’s immediate goal is to support early-stage dentist-scientists such as post-doctoral scholars and pre-tenure faculty members, with a long-term objective of increasing the number of successfully funded dentist-scientists ...
Mass General Brigham researchers present key findings at ASCO
2025-05-30
Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30-June 3, in Chicago.
ASCO brings together leading experts in clinical oncology to share the latest breakthroughs in cancer research, science and medicine. Presentations from Mass General Brigham investigators include an update on the INCIPIENT trial (using CAR-T in patients with glioblastoma), advances in skin cancer and gynecologic cancer treatment, a new way to radiate multiple brain metastases at the same time, and an app created to help caregivers ...
Student researchers put UTA on national stage
2025-05-30
University of Texas at Arlington biochemistry major Debby Sunday showcased her research at a recent American Chemistry Society conference at East Texas A&M in Commerce. Her findings on photosynthesizers and bacteria earned second place in the undergraduate competition.
“This was the first research conference I ever attended, and my experience was very educational,” said Sunday, a graduate of Lake Ridge High School in Mansfield. “Other chemists from across the metroplex presented their various research, from inorganic chemistry to physical chemistry to biochemistry. Not ...
Hertz Foundation and Breakthrough Energy partner to advance climate and energy solutions
2025-05-30
The Hertz Foundation, a nonprofit dedicated to empowering the nation’s most promising innovators in science and technology, and Breakthrough Energy Discovery, a Breakthrough Energy platform focused on pre-venture, early-stage clean technology, have announced a new partnership to advance transformative climate and energy solutions.
This collaboration brings together two organizations with a shared commitment to advancing scientific innovation and supporting exceptional talent. By connecting Breakthrough Energy’s innovation platform with the Hertz Foundation’s renowned community of scientific leaders, the partnership will create new opportunities ...
New study reveals how tiny insects detect force
2025-05-30
HUNTINGTON, W.Va. — A newly published study in the Journal of Neurophysiology reveals how blow flies (Calliphora vicina)—despite their minimal body weight—reliably detect forces through specialized sensory organs in their legs. The research offers new insights into insect biomechanics and presents promising applications for the design of next-generation walking robots.
Researchers at Marshall University and West Virginia University examined the behavior of campaniform sensilla—strain-detecting ...
New 3D genome mapping technology sheds light on how plants regulate photosynthesis
2025-05-30
Chinese researchers have developed a groundbreaking technology that sheds light on how the three-dimensional (3D) organization of plant genomes influences gene expression—especially in photosynthesis.
The research, which was led by Prof. XIAO Jun at the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences, in collaboration with BGI Research, was published in Science Advances on May 30.
The innovative method not only provides a more precise tool for understanding the intricate 3D interactions between genes, but also highlights the critical role of long-range chromatin interactions ...
Dinosaur eggshell study confirms biogenic origin of secondary eggshell units
2025-05-30
The calcitic layers of the eggshells of archosaurs (including crocodilians and birds) and turtles are composed of distinctive crystalline structures known as eggshell units. Those growing from the shell membrane are called primary eggshell units (PEUs), while those forming within the calcitic layer are called secondary eggshell units (SEUs). Although rare in modern bird eggs, SEUs are common in dinosaur eggs. Due to the lack of in-depth research on this structure, however, scientists are uncertain whether they are biogenic or abiogenic in origin.
To tackle this issue, an international ...
Transforming immunotherapy design
2025-05-30
The University of Pittsburgh’s Natasa Miskov-Zivanov, assistant professor of electrical and computer engineering, has received a prestigious Faculty Early Career Development (CAREER) Award of $581,503 from the National Science Foundation (NSF) for her project titled “Artificial Intelligence-Driven Framework for Efficient and Explainable Immunotherapy Design.” Through her novel approach and the development of an automated system that leverages AI and knowledge graphs to design more effective lymphocytes, she hopes to transform the ...
New book with a global view of men’s experiences with partner violence
2025-05-30
More than two decades ago, Denise Hines began investigating a topic most researchers wouldn’t touch: men as victims of intimate partner violence (IPV). She and collaborator Emily Douglas were the first in the U.S. to earn federal funding for this line of research, publishing studies that challenged entrenched gender assumptions and provoked debate in the field.
Their new book, The Routledge Handbook of Men’s Victimization in Intimate Relationships, offers the most thorough international synthesis ...
LAST 30 PRESS RELEASES:
Endophytic fungi from halophyte Sesuvium portulacastrum enhance maize growth and salt tolerance
Quality of kids’ diets linked with dad’s eating habits as a teen
Alliance trial shows dual immunotherapy improves progression-free survival in advanced squamous cell skin cancer
Insights from immunotherapy trial inform new approaches to treating advanced skin cancer
Genome breakthrough reveals secrets behind rapid growth and invasiveness of tropical vine Merremia boisiana
Transforming the certification process of 3D-printed critical components
UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
UT Health San Antonio researchers discover new links between heart disease and dementia
AADOCR announces new SCADA/Dentsply Sirona Research Award
Mass General Brigham researchers present key findings at ASCO
Student researchers put UTA on national stage
Hertz Foundation and Breakthrough Energy partner to advance climate and energy solutions
New study reveals how tiny insects detect force
New 3D genome mapping technology sheds light on how plants regulate photosynthesis
Dinosaur eggshell study confirms biogenic origin of secondary eggshell units
Transforming immunotherapy design
New book with a global view of men’s experiences with partner violence
New research recovers evidence for lost mountains from Antarctica’s past
Scientists discover new evidence of intermediate-mass black holes
Predicting underwater landslides before they strike
What will it take to reduce primary care doctor burnout?
Small currents, big impact: Satellite breakthrough reveals hidden ocean forces
Single-atom catalysts change spin state when boosted by a magnetic field
Integrated metasurface for quantum analog computation: A new scheme to phase reconstruction
PolyU research reveals rising soil nitrous acid emissions driven by climate change and fertilisation accelerate global ozone pollution
The EU should allow gene editing to make organic farming more sustainable, researchers say
At-home heart attacks and cardiac deaths on the rise since COVID-19 pandemic
Projected outcomes of removing fluoride from U.S. public water systems
Parental education, own education, and cognitive function in middle-aged and older adults
Sacred moment experiences among internal medicine physicians
[Press-News.org] UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancerClinical trial tests new treatment approach, offers hope for personalized therapies